NCS News
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
Written By: Preethi Ramchand
Standard medical and surgical treatment options for chronic subdural hematoma (SDH) are associated with rates of treatment failure approaching...
NCS News, President's Update
President's Update - October 2025
Written By: David M. Greer, MD, MA, FCCM, FAHA, FNCS, FAAN, FANA
As this is my first presidential message, I would like to take this opportunity to express my gratitude for the honor and privilege of serving you...
NCS News
Introducing the 2025 Annual Issue of 'Currents'
Written By: Michael Reznik, MD; Jordan Yakoby, EdD, DNP, ACNP-BC, CCRN, CNE, FNYAM, FCCM, FNCS
The Neurocritical Care Society (NCS) is proud to launch the 2025 Issue of Currents, featuring a compilation of content published...
NCS News
President's Update - September 2025
Written By: Susan Yeager, DNP, RN, CCRN, ACNP-BC, FNCS
As we welcome September, I also share my final letter as the president of the Neurocritical Care Society. With the change in seasons comes a...
NCS News
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
Written By: Brendan Baugher, DO, MS; Alexander Lewis, DO
The optimal duration of antibiotic therapy for bloodstream infections remains uncertain. Prolonged courses of antibiotics may increase iatrogenic...
NCS News, President's Update
President's Update - August 2025
Written By: Susan Yeager, DNP, RN, CCRN, ACNP-BC, FNCS
Welcome to August! As we prepare for a busy and energizing fall season, I hope you’re finding time to recharge and reconnect – with...
NCS News
Honoring Through Action: The HEARD Center Story
Written By: Tommy Thomas, MD, PhD; Aimee Aysenne, MD, MPH
“I remember so many days with Galen in the Brigham (and Woman’s Hospital) ICU as resident and fellow. We would often share stories of...
NCS News
Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial
Written By: William Spears, MD
Background: The recently published ARCADIA trial, which enrolled patients with ESUS and signs of atrial cardiopathy, failed to show that...